| |
|
|
|
Scientific research in two different drug in patients with schizophrenia and depression, "positive" results showed that.
The most comprehensive convention held in Turkey in the treatment of psychiatric disorders, the "5th International Congress of Psychopharmacology", held in Antalya by the Association of Psychopharmacology. Head of the Congress. Dr. Mesut Cetin, at a press conference of the congress this year, "our minds in the brain" slogan, in line with the treatment of mental disorders by the participants from all over the world, and said they discussed innovations in drugs. depression affects one-fifth of the world's population Professor. Dr. Cetin, depression, and suicide completion affecting nearly one fifth of the world's population at risk is a significant health problem, he added. often interrupt the treatment may leave patients with the treatment of depression, it also carries a serious risk Cetin emphasized in recent years, the data for the development of new drugs to treat depression associated with an increased success has been achieved, he said.possible to treat depression in a few hours Head of Department of Pharmacology, Faculty of Pharmacy, University of Marmara. Dr. Feyza the rat, the last 10 years, significant research was done to understand the mechanisms of the brain, and the findings were important, he said. Especially in the last two years, important steps have been taken in this area emphasizes the rat, "America's prestigious universities in Canada and the U.S. with the special permission of the National Institute of Mental Health these studies are carried out, in fact, exist on the market, which is used for a different treatment of the two drugs, used to treat schizophrenia and depression show, "he said. Arıcıoğlu it on psychiatry in recent years to be among the most dynamic and exciting developments, pointing to the "drug, nose scheduled for the market, such as easy to use spray. drug in question, in cases that do not respond to treatment with other drugs antidepressant effect was obtained as soon as a few hours, "he said. expressing the rat studies, continuing, said: "Drugs are already available in the market at the moment, but blood pressure lower (hypertension), and the areas of anesthesia used. These dose of what to do with what you were supposed to have an impact in terms of molecules in schizophrenia and depression. Beneficial effects of the drug were to be released, but the process will take and ruhsatlanması. acceptable level of side effects and harm to the patient need to be sure that . Pharmaceutical market exists, ensure the safety of the process much shorter when there. everything goes well and regulations for the use of drugs to treat depression resistant to treatment condition were available in both cases will be seen within hours of recovery can be achieved as well as the influence of drugs. these new drugs, schizophrenia and depression seems to be good news for patients. Studies as a result can be achieved, these patients have long term impact of drug use several times a year can be an outstanding approach to treatment. However, not all of them currently under review. new drug, frequency of use of the drug may be reduced, but a lifetime of patients according to current knowledge, you need to use. |
|
|
0 comments:
Post a Comment